![William Collier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Collier
Director/Miembro de la Junta en Genevant Sciences Corp. .
Fortuna: - $ al 31/05/2024
Cargos activos de William Collier
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Miembro de la Junta | - | - |
Historial de carrera de William Collier
Antiguos cargos conocidos de William Collier.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Director/Miembro de la Junta | 24/06/2019 | 31/12/2023 |
Director Ejecutivo | 24/06/2019 | 31/12/2023 | |
Contacto de Relaciones con Inversores | 24/06/2019 | 21/09/2021 | |
Public Communications Contact | 24/06/2019 | - | |
Presidente | 24/06/2019 | 31/12/2023 | |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Director Ejecutivo | - | 31/12/2023 |
Presidente | - | 31/12/2023 | |
International Partnership for Microbicides
![]() International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Director/Miembro de la Junta | 01/01/2018 | 01/01/2021 |
Aids United | Director/Miembro de la Junta | 01/01/2011 | 01/01/2018 |
Glaxowellcom | Corporate Officer/Principal | - | - |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Presidente | - | - |
Formación de William Collier.
University of Manchester Institute of Science & Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 3 |
Canadá | 2 |
Operativa
Director/Board Member | 4 |
President | 3 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Empresas privadas | 6 |
---|---|
International Partnership for Microbicides
![]() International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Health Technology |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
Glaxowellcom | |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
Aids United |
- Bolsa de valores
- Insiders
- William Collier
- Experiencia